Market Value1,787,596,851
Total Holdings62
File Date2024-08-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SYBX / Synlogic, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
Shockwave Med Inc / (SHOCKWAVE)
Invesco QQQ TR / UNIT SER 1 (46090E953)
CRSP / CRISPR Therapeutics AG Put
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
AXSM / Axsome Therapeutics, Inc.
CBAY / CymaBay Therapeutics, Inc.
CBAY / CymaBay Therapeutics, Inc. Put
IWM / iShares Trust - iShares Russell 2000 ETF Put
SNDX / Syndax Pharmaceuticals, Inc. Put
ALKS / Alkermes plc
ELAN / Elanco Animal Health Incorporated
ISRG / Intuitive Surgical, Inc.
AVTE / Aerovate Therapeutics, Inc.
MRNS / Marinus Pharmaceuticals, Inc. Call
SPY / State Street SPDR S&P 500 ETF Trust Put
PEN / Penumbra, Inc.
CYTK / Cytokinetics, Incorporated
REPL / Replimune Group, Inc. Call
REPL / Replimune Group, Inc.
REPL / Replimune Group, Inc. Put
SYK / Stryker Corporation
YMAB / Y-mAbs Therapeutics, Inc.
GRTX / Galera Therapeutics, Inc.
VIR / Vir Biotechnology, Inc.
RYZB / RayzeBio, Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
IMGN / ImmunoGen, Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
MRK / Merck & Co., Inc.
PODD / Insulet Corporation
CLDX / Celldex Therapeutics, Inc.
AGEN / Agenus Inc. Call
AGEN / Agenus Inc.
INBX.V / Inhibrx, Inc.
FUSN / Fusion Pharmaceuticals Inc.
PDSB / PDS Biotechnology Corporation
MLTX / MoonLake Immunotherapeutics
14161H108 / Cardtronics PLC
ARGX / argenx SE - Depositary Receipt (Common Stock)
KRTX / Karuna Therapeutics, Inc.
ASND / Ascendis Pharma A/S
IMVT / Immunovant, Inc.
PEPG / PepGen Inc.
Cooper Cos Inc / (216648402)
Nucana PLC / SPONSORED ADR (67022C106)
SPRB / Spruce Biosciences, Inc.
INCY / Incyte Corporation
CLDX / Celldex Therapeutics, Inc. Put
CABA / Cabaletta Bio, Inc.
SRPT / Sarepta Therapeutics, Inc. Call
KURA / Kura Oncology, Inc.
SNDX / Syndax Pharmaceuticals, Inc. Call
INZY / Inozyme Pharma, Inc.
EXEL / Exelixis, Inc.
EXEL / Exelixis, Inc. Put
IDXX / IDEXX Laboratories, Inc.
IKNA / Ikena Oncology, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
GERN / Geron Corporation
IMTX / Immatics N.V.
SLNO / Soleno Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
DYN / Dyne Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
SVRA / Savara Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
BOLT / Bolt Biotherapeutics, Inc.
BSX / Boston Scientific Corporation
DXCM / DexCom, Inc.
VERA / Vera Therapeutics, Inc.
NTRA / Natera, Inc.
IMTXW / Immatics N.V. - Equity Warrant
CYTK / Cytokinetics, Incorporated Put
FULC / Fulcrum Therapeutics, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
KVUE / Kenvue Inc.
NXTC / NextCure, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
LLY / Eli Lilly and Company
MASI / Masimo Corporation
PHVS / Pharvaris N.V.